FDA Announces Release of Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market
🔹The U.S. Food and Drug Administration (FDA) released a Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market. The strategy builds on the Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula MarketExternal Link Disclaimer which was released in early 2023 in direct response to the February 2022 infant formula recall … Read more